Inadequate Controls, Faulty Test Methods Lead to Form 483 for Softech Pharma By Sam | February 1, 2017 The FDA came down on Softech Pharma, handing them a Form 483 after an inspection of their India facility revealed 12 issues. Source: Drug Industry Daily Posted in Drug Industry Daily